WFCF:NASDAQWhere Food Comes From, Inc. Analysis
Data as of 2026-06-15 - not real-time
$11.59
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The stock is trading at $11.59, which sits below its 20‑day (11.71), 50‑day (12.31) and 200‑day (12.25) simple moving averages, indicating a short‑term bearish bias. Yet the MACD histogram is positive and the MACD line sits above its signal, giving a modest bullish signal. The RSI of 48 suggests the shares are neither overbought nor oversold, reinforcing a neutral market stance. Volume has been shrinking, with daily trades well under the 10‑day average, hinting at waning liquidity. Volatility is extreme at 179% over the past 30 days, and the beta of 0.92 shows the stock moves roughly in line with the market but with amplified swings. Valuation metrics are stretched: a trailing PE of 37.4 far exceeds the industry average of 31, while the DCF‑derived fair value of $4.13 implies the market price is more than double intrinsic estimates.
Fundamentally, revenue of $24.98 million grew only 1.7% YoY and margins remain thin (gross 37%, operating 5.5%, net 6.4%). Return on equity is respectable at 17%, but a debt‑to‑equity ratio of 9.1 signals heavy leverage relative to a modest equity base. The company holds ample cash ($3.28 million) against $0.84 million of debt, mitigating immediate solvency concerns. No dividend is paid, and the payout ratio is zero, so income‑focused investors find little appeal. The business operates in the U.S. specialty verification niche, exposing it to moderate regulatory scrutiny but limited geographic concentration risk. Combined with the extreme greed sentiment index (92.5) and the lack of clear growth catalysts, the stock appears overvalued and best approached with caution.
Fundamentally, revenue of $24.98 million grew only 1.7% YoY and margins remain thin (gross 37%, operating 5.5%, net 6.4%). Return on equity is respectable at 17%, but a debt‑to‑equity ratio of 9.1 signals heavy leverage relative to a modest equity base. The company holds ample cash ($3.28 million) against $0.84 million of debt, mitigating immediate solvency concerns. No dividend is paid, and the payout ratio is zero, so income‑focused investors find little appeal. The business operates in the U.S. specialty verification niche, exposing it to moderate regulatory scrutiny but limited geographic concentration risk. Combined with the extreme greed sentiment index (92.5) and the lack of clear growth catalysts, the stock appears overvalued and best approached with caution.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- price below key moving averages
- high volatility and decreasing volume
- valuation far above fair value
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- modest bullish MACD signal
- stable cash position despite leverage
- potential upside from innovative programs mentioned in news
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- thin margins limit growth
- heavy debt‑to‑equity ratio
- absence of dividend and limited growth catalysts
Key Metrics & Analysis
Financial Health
Revenue Growth1.70%
Profit Margin6.39%
P/E Ratio37.4
ROE17.00%
ROA5.99%
Debt/Equity9.10
P/B Ratio6.3
Op. Cash Flow$1.5M
Free Cash Flow$1.3M
Industry P/E31.0
Technical Analysis
TrendNeutral
RSI48.4
Support$9.55
Resistance$16.00
MA 20$11.71
MA 50$12.31
MA 200$12.25
MACDBullish
VolumeDecreasing
Fear & Greed Index92.5
Valuation
Fair Value$4.13
GradeOvervalued
TypeValue
Risk Assessment
Beta0.92
Volatility179.13%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.